Silicon Forest
  • Economic Summit
    • About
    • Contact
  • Contact
  • Join
  • Donate
  • Home
  • Technology and Innovation
  • Massive Study: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients

Massive Study: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients

on March 2, 2022
in Technology and Innovation
Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients

Share this:

  • Twitter
  • Facebook
  • More
  • LinkedIn
  • Reddit
  • Tumblr
  • Pinterest
  • Pocket
  • Telegram
  • WhatsApp
  • Skype
  • Email

Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients – By the International Journal of Infectious Diseases

Purpose

To evaluate the difference in mortality of patients treated with ivermectin vs patients treated with remdesivir with COVID-19 in United States using TriNetX Research network, a federated EMR network of over 44 healthcare organizations and 68 million patients from US, from 2009-2021.

Methods & Materials

We retrospectively identified adults (≥18 years) with a recorded COVID-19 infection between January 1, 2020 and July 11, 2021. We compared those with recorded use of ivermectin, but not remdesivir, against those with recorded use of remdesivir, but not ivermectin. We controlled for the following demographics, comorbidities, and treatments that may affect COVID-19 survival outcomes: age, gender, race, ethnicity, nicotine use diabetes mellitus, obesity, chronic lower respiratory disease, ischemic heart diseases, tocilizumab, glucocorticoids, or ventilator use. We measured association with mortality as the primary outcome, with significance assessed at p<0.05.

Results

There were a total of 1,761,060 possible COVID-19 patients based on ICD-10 diagnostic terms and confirmatory lab results. Prior to controlling, our analysis yielded 41,608 patients who had COVID-19 resulting in two unique cohorts that were treated with either ivermectin (1,072) or remdesivir (40,536). Within the ivermectin cohort, average age was 51.9 + 17.8 years, 43% were male, 60% had glucocorticoids and 1% required ventilator support. In the remdesivir cohort, average age was 62.0 + 16.0 years, 54% were male, 64% had glucocorticoids and 2% required ventilator support. After using propensity score matching and adjusting for potential confounders, ivermectin was associated with reduced mortality vs remdesivir (OR 0.308, 95% CI (0.198,0.479)),Risk Difference -5.224%, CI (-7.079%,-3.369%), p <0.0001.

Conclusion

Ivermectin use was associated with decreased mortality in patients with COVID-19 compared to remdesivir. To our knowledge, this is the largest association study of patients with COVID-19, mortality and ivermectin. Further double-blinded placebo-controlled RCTs with large samples are required for definite conclusion. In the future, if more publications are published with the similar result to the current analyses, the certainty of evidence will increase.

1-s2.0-S1201971221009887-main

Massive Study: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients

Related

Covid-19 Ivermectin Remdesivir
Previous THE HOLY ALLIANCE (WHITE ARMY) Next Amazing Polly MEGA BOOM! Klaus Schwab's Global Shapers Network Exposed!

0 Comments for “Massive Study: Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients”

Leave a Reply Cancel reply

You must be logged in to post a comment.

Categories

  • Agenda
  • Conspiracy Theory
  • Economy
  • Investing Trends
  • News Media
  • Politics
  • Religion
  • Technology and Innovation
Nothing can stop what is coming

Archives

  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
Menu
  • Economic Summit
    • About
    • Contact
  • Contact
  • Join
  • Donate